Daily Use of Whitening
Strips on Tetracycline-
Stained Teeth: Comparative CE 4

Results After 2 Months
Gerard Kugel, DMD, MS
Dean for Research

Abstract: This article reviews the efficacy of a new 6.5% hydrogen peroxide
tooth-whitening gel strip for bleaching teeth that have been intrinsically stained

Ayman Aboushala, DDS, MS
from tetracycline. Given the severity of staining in the cases presented during a
recently conducted clinical trial, the resulting efficacy is dramatic. Additionally,
Tufts University School of Dental Medicine the continuous use of these strips for 30 minutes per day, twice daily for 2
months with no meaningful adverse effects is noteworthy.
Xiaojie Zhou, PhD
In cases requiring esthetic enhancement of discolored dentition, those involv- Statistician ing tetracycline stains are among the most challenging. These intrinsic stains, Robert W. Gerlach, DDS, MPH
which cannot be removed with polishing or abrasive mechanisms, may result from the administration of tetracycline during childhood for the treatment of disease. The color and severity of stains vary and are influenced by the duration of tetracycline use, and the stage of tooth development at the time the medica-tion was prescribed.
While some patients may select veneers or full-coverage crown restorations to brighten their smiles, others may desire a more conservative approach. To thatend, tooth whitening offers a simplified and economical alternative for changing Learning Objectives
When clinicians are faced with the prospect of whitening a patient’s intrin- sically stained teeth, considerations for treatment include the shade and location of discoloration,1 as well as which formulation of whitening solutions to use.
Whether whitening should take place in the office or at home under the den- tist’s supervision, along with the longevity of the whitening protocol, must also be decided. It has been suggested that when discoloration appears at the cervical area of the tooth, the whitening results may be poorest; when the stain is dark gray or blue, the prognosis is similarly unimpressive. When whitening tetracy- cline-stained teeth, patients may need to commit to a course of treatment last- Treatment commonly involves the use of at-home vital bleaching kits, which polyethylene film whiten-ing system with a tray were first introduced in 1989.5 According to some reports, tetracycline-stained teeth have demonstrated a favorable prognosis depending on the treatment protocol,although they are the most resistant to bleaching.6 Specifically, one report showedthat 97% of patients with tetracycline stains experienced successful tooth lighten-ing when a carbamide peroxide whitening solution was used in a nightguard.2 A recently introduced 6.5% hydrogen peroxide whitening delivery system (Crest® Professional Whitestripsa) shows promise for whitening tetracycline-stained dentition when used at home for 2 months under a dentist’s supervision.
The hydrogen peroxide–coated polyethylene strips represent an alternative forpatients who cannot afford other whitening treatments and/or do not have timefor multiple dental visits.7 This article presents the recent research findings of aclinical trial designed to evaluate the efficacy of two at-home vital bleaching sys-tems on tetracycline-stained teeth.
a The Procter & Gamble Co, Cincinnati, OH 45202; 800-492-7378 Compendium / Special Issue
products were packaged in 1-month product CE 4
kits, and all labeling was identical except for a efficacy of two at-home vital bleaching sys- unique subject identification number.
tems on tetracycline-stained teeth. Daily bleaching was conducted for 2 months.
vised for instructional purposes, but all other Eligibility was limited to healthy adult volun- treatment was unsupervised. Only the maxil- lary arch was treated. Participants in the strip including at least 3 gradable maxillary incisors group were instructed to wear a whitening with significant tetracycline staining. In- strip for 30 minutes twice daily. Individuals in dividuals demonstrating tooth sensitivity or the tray group had a custom soft, full-arch an immediate need for dental treatment were bleaching tray fabricated with gingival scal- excluded from participating in this trial.
loping and gel reservoirs using materials sup-plied by the manufacturer. Subjects in thatgroup were instructed to place half to threequarters of the contents of a bleaching syringeinto the custom tray and wear the device for In cases requiring esthetic
enhancement of discolored
dentition, those involving
tetracycline stains are among
beginning of the study and again each monthafter treatment. First, the level of tetracycline the most challenging.
staining on the maxillary anterior teeth wasassessed using a modified standard index.8 This modification recognized the possibility of and advertising were reviewed and approved successfully bleaching teeth with relatively by Tuft University’s Institutional Review severe tetracycline stain (Table 1). These Board. Written and verbal informed consent baseline values, along with age, were used for was received before study initiation. After balance and assignment during treatment ran- informed consent was obtained and baseline domization. Efficacy was assessed using a stan- measurements were made, subjects were dard 16-step value-oriented tooth shade guidecrandomized 3:1 to a strip-based, hydrogen to match artificial crowns to the natural den- peroxide tooth-whitening system (Crest® Pro- tition. Shade assessments were made in a neu- fessional Whitestrips) or a marketed tray- tral-colored dental operatory under color-bal- based, carbamide peroxide whitening system anced lighting conditions by a trained and calibrated examiner. Tolerability was assessed by intraoral examination and subject report at frice (Crest® Cavity Protection Regular Pastea) and an extrasoft toothbrush (Crest® Com- pletea) for use throughout the study. All test by ranking the 16 shade tabsc, arranged from b Ultradent Products, Inc, South Jordan, UT 84095; 800-552-5512 dark to light, according to the rank order sug-gested by the manufacturer. To account forunusually dark colors (often seen with tetracy-cline staining) or white colors (often seen Table 1—Tetracycline Stain Classification*
postbleaching), this 16-step guide was supple- Clinical Presentation
mented by 2 additional values (C4+ and B1–) representing shades darker than C4 or lighter Uniform light yellow, brown, or gray stain confined to than B1. Effectiveness was determined by cal- culating the change in shade scores from base-line at each posttreatment visit. Using this Deep yellow, brown, or gray stain, without banding method, a decrease in numeric shade score Dark gray or blue stain with marked banding represented an increase in tooth whiteness.
Treatment groups were compared using analy- c Vita Zahnfabrik, Germany; distributed in the US by Vident™, Brea, CA Compendium / Special Issue
sis of covariance with the baseline shade as the more severe banding that is occasionally CE 4
the covariant. Comparisons to baseline were reported after childhood antibiotic use. While tobacco use was uncommon (15% of subjects), were 2-sided using a 5% significance level. 95% of the study participants consumed cof-fee, tea, or cola beverages daily. Treatment respect to demographic and behavioral param- eters and tetracycline stain levels (Table 2). assigned to the tray group. The study popula- Both treatments were effective overall in tion ranged from 22 to 70 years of age.
improving the shade of tetracycline-stained Approximately half of the subjects presented teeth (Table 3). Relative to baseline, the 2 with moderate-to-severe tetracycline staining groups averaged approximately 4.1 to 6.6 units (levels II through IV), a third of whom had of shade improvement after 2 months of treat- Table 2—Baseline Demographic, Behavioral, and Tooth Shade Information
Demographic, Behavioral
Age (years)
Tobacco Use
Daily Coffee/Tea/
Cola Consumption

Tetracycline Stain

Tooth Shade
Compendium / Special Issue
CE 4
Table 3—Tooth Shade by Treatment and Time
Between-Group Comparison
Comparison to Baseline
Mean Treatment
Mean Shade Change
Difference (SE)
Table 4—Tooth Sensitivity and Oral Irritation
Strip (n = 30)
Tray (n = 10)
Overall (n = 40)
Number of
Number of
Number of
clinical manifestations present at the 1-month greater after 2 months than after 1 month. or 2-month clinical examinations. Seven sub- Response was faster in the strip group.
jects discontinued treatment during the first 2 During the first month of treatment, the strip months (3 in the tray group and 4 in the strip group averaged more than a 4-unit reduction group). Of these, 2 individuals in the tray in tooth shade, which represented a statisti- group reported the regimen was inconvenient cally significant (P < 0.0001) improvement vs and withdrew after the 1-month visit. The baseline. In contrast, the tray group averaged remaining patients withdrew because of an less than a 1-shade reduction during the first inability to make the scheduled recall appoint- month, not differing statistically from baseline (P > 0.10). Adjusting for baseline, the strip modifying their treatment regimen because of group averaged 2.6 to 3.2 units greater shade reduction than the tray-group control. Withrespect to between-group comparisons, thestrip group experienced statistically significantsuperior reductions (P < 0.01) in shade com- The strip group averaged
pared with the tray group at both the 1- and 2- 2.6 to 3.2 units greater
shade reduction than the tray-
Both treatments were generally well toler- group control.
ated. Mild and transient tooth sensitivity andoral irritation were the most common adverseevents associated with daily bleaching (Table Discussion
4). These events typically were reported early This study was designed to evaluate clin- in the treatment regimen, and there were no ical response after longer-term, daily use of Compendium / Special Issue
CE 4
Figure 1A—Pretreatment tooth color.
Figure 1B—After 2 months of daily bleach- Figure 1C—After 2 months of daily bleach-
ing with whitening strips compared with
Figure 2A—Pretreatment tooth color.
Figure 2B—After 2 months of daily bleach- Figure 2C—After 2 months of daily bleach-
ing with whitening strips compared with
6.5% hydrogen peroxide whitening strips.
greater shade improvement overall compared to the tray control group. While overnight treatment in individuals with tetracycline tray use may improve clinical response in that staining because this clinical condition is group, such daily treatment conducted over reported to require extended treatment of the long term could also affect subject com- ingful whitening.9 A marketed 10% car-bamide peroxide, tray-based system wasselected as the control group because thisagent has been used previously and reported The use of whitening strips has
to be effective in longer-term studies of tetra- been proposed as a viable
cycline staining.10,11 Other concentrations option for longer-term whitening
because of favorable compliance,
tems were effective, with both groups differ- lower systemic exposure, and other
ing significantly from baseline at the end of factors associated with this easy-
to-use bleaching system.
response in the strip group was superior to thetray group, as evidenced by the significant (P< 0.01) between-group treatment differences, favoring the “trayless” whitening strip system, was impressive (Figures 1A through 2C).
at both 1 and 2 months. Onset of these clini- However, this study confirms early observa- cal benefits was more rapid in the strip group.
tions that extended contact time is needed in After 1 month of treatment, the strip group months of daily treatment, involving approxi- than 4 shades compared to less than 1 shade mately 60 hours of strip use or 120 hours of tray in the tray group. Also, only the strip group use, no subjects had yet reached the predeter- experienced statistically significant improve- mined bleaching cutoff, B1. Additional treat- ments in tooth color after 1 month. After 2 ment time may be necessary in these subjects Compendium / Special Issue
CE 4 treatment, hence the time point elected for
The research was supported by The Procter this study.12 The researchers expect to contin- ue treatment and observation of this studypopulation for up to 6 months to further assess References
the effectiveness and tolerability of these Haywood VB, Leonard RH, Nelson CF, et al: Effectiveness,side effects and long-term status of nightguard vital bleach- ing. J Am Dent Assoc 125(9):1219-1226, 1994.
Twice-daily use of the 6.5% hydrogen per- Haywood VB, Leonard RH, Dickinson GL: Efficacy of six oxide whitening strips was well tolerated over months of nightguard vital bleaching of tetracycline-stained the 2-month treatment period. The side effects teeth. J Esthet Dent 9(1):13-19, 1997.
Haywood VB: Extended bleaching of tetracycline-stained in this study—transient tooth sensitivity and teeth. Contemp Esthet Rest Prac 1(1):14-21, 1997.
gingival irritation—generally were similar in Haywood VB: Bleaching tetracycline-stained teeth. Esthet nature and severity to the primary events Haywood VB, Heymann HO: Nightguard vital bleaching.
reported in other longitudinal trials using the Quintessence Int 20(3):173-176, 1989.
at-home tray-bleaching systems.9 In the cur- Haywood VB, Leonard RH, Nelson CF: Efficacy of 6- rent study, where the whitening strips were months’ nightguard vital bleaching of tetracycline-stainedteeth [abstract #2358]. J Dent Res 73, 1994. used for a total of 60 contact hours over a 2- Kugel G: Nontray whitening. Compend Contin Educ Dent month period, no subject in the strip group dis- continued treatment because of an adverse Boksman L, Jordan RE: Conservative treatment of thestained dentition: vital bleaching. Aust Dent J 28(2):67-72, event. This extended exposure associated with long-term, daily treatment of tetracycline stain Leonard RH: Nightguard vital bleaching: dark stains and corroborates and extends the safety of strip- long-term results. Compend Contin Educ Dent 21(suppl based tooth whitening as reported in earlier, Leonard RH, Haywood VB, Eagle JC, et al: Nightguard vital bleaching of tetracycline-stained teeth: 54 months post treat-ment. J Esthet Dent 11(5):265-277, 1999.
Matis BA, Wang Y, Jiang T, et al: Six-month evaluation ofbleaching agents in patients with tetracycline staining The use of whitening strips has been pro- [abstract #1175]. J Dent Res 80:182, 2001.
Haywood VB: Current status of nightguard vital bleaching.
whitening because of favorable compliance, Compend Contin Educ Dent 21(suppl 28):S10-S17, 2000.
Gerlach RW: Shifting paradigms in whitening: introduction lower systemic exposure, and other factors of a novel system for vital tooth bleaching. Compend Contin associated with this easy-to-use bleaching sys- Educ Dent 21(suppl 29):S4-S9, 2000.
tem.14 New clinical research involving extend- Kugel G, Kastali S: Tooth whitening efficacy and safety: arandomized and controlled clinical trial. Compend Contin ed treatment of tetracycline stain for 2 months Educ Dent 21(suppl 29):S16-S21, 2000.
confirms this proposition. In the current study, Gerlach RW, Jeffers MJ, Pernik PS, et al: Impact of prior tooth brushing on whitening strip clinical response [abstract hydrogen peroxide whitening strip provided #922]. J Dent Res 80:151, 2001.
Gerlach RW, Campolongo KL, Hoke PD, et al: Use of per- efficacy similar to 2 months of treatment with oxide-containing polyethylene strips: effect of dosing dura- a 10% carbamide peroxide tray system.
tion on initial and sustained shade change [abstract #920]. J Dent Res 80:150, 2001.
Gerlach RW, Gibb RD, Sagel PA: A randomized clinical trial Acknowledgments
comparing a novel 5.3% hydrogen peroxide whitening strip to 10%, 15%, and 20% carbamide peroxide tray-based tions of Lisa Bowman, AS, Senior Researcher, bleaching systems. Compend Contin Educ Dent 21(suppl29):S22-S28, 2000.
Clinical Data Management; Donna McMillan, McMillan DA, Gibb RD, Gerlach RW: Impact of increasing PhD, Principal Scientist, Toxicology; Sarah hydrogen peroxide concentration on bleaching strip efficacy Towers, Research Administrator; and Patricia and tolerability [abstract #1102]. J Dent Res 80:173, 2001.
Swift EJ, Heymann HO, Ritter AV, et al: Clinical evaluation of a novel “trayless” tooth whitening system [abstract #921].
Clinical Trials Management, to this research.
Compendium / Special Issue

Source: http://www.the-o-zone.cc/HTMLOzoneF/abstracts/ab197.pdf


Dolman G, Parry SD. (2011)An unusual cause of aortic-enteric fistula in a young man. Submitted to Gastroenterology Update 2011Saligram S, Parry SD. (2010)Role of hydrogen breath test in management of small bowel bacterial overgrowth. Poster and abstract at AMA-RFS 2010 Interim Meeting San Diego Nov 5 2010; Winner of Pennsylvania Western 2010 Abstract Competition. Conti

Smar n112

S ANTÉ ET PRÉVENTION Alli® est en vente sans ordonnance dans les pharmacies. Mais cette pilule contre le surpoids n’est ni une nouveauté ni un remède miracle. C’est la version à moitié dosée d’un médicament ancien, le Xenical®, qui s’est révélé inefficace contre l’obésité. Son mode d’action :l’évacuation des graisses dans les selles, au prix de diarrhées parfoi

© 2010-2018 Modern Medicine